Search / 257 results found

from
to

AUSTIN, Texas and LONDON, England, Feb. 24, 2021 (SEND2PRESS NEWSWIRE) — Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a collaboration agreement with King’s College London, a leading university providing world-class teaching and cutting-edge research, to support the Phase IIa GAMECHANgER-1 clinical trial.

  • Updated

Humans are making Earth a broken and increasingly unlivable planet through climate change, biodiversity loss and pollution. So the world must make dramatic changes to society, economics and daily life, a new United Nations report says.

  • Updated

SEATTLE, Feb. 18, 2021 /PRNewswire/ -- The gut microbiome is an integral component of the body, but its importance in the human aging process is unclear. ISB researchers and their collaborators have identified distinct signatures in the gut microbiome that are associated with either healthy or unhealthy aging trajectories, which in turn predict survival in a population of older individuals. The work will be published February 18 in the journal Nature Metabolism. (Once published, the article can be accessed here.)

  • Updated

WASHINGTON, Feb. 17, 2021 /PRNewswire/ -- An article published in Experimental Biology and Medicine (Volume 246, Issue 4, February, 2021) (https://journals.sagepub.com/doi/pdf/10.1177/1535370220966296) reports a new mechanism for modulating transforming-growth factor beta (TGF-β) signaling. The study, led by Dr. Thomas Thompson, in the Department of Molecular Genetics, Biochemistry and Microbiology at the University of Cincinnati College of Medicine in Cincinnati, Ohio (USA), proposes a new mechanism for follistatin antagonism of TGF-β signaling.